Floatz logo

377 assets in Pancreatic Neoplasm

Therapeutic assets addressing Pancreatic Neoplasm, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Balstilimab
Pancreatic Neoplasm
Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsP1/2CC (45)
CD318-CAR-T cells
Pancreatic Neoplasm
University Hospital TuebingenP1/2CC (45)
Cdx 1140
Pancreatic Neoplasm
Washington University School of MedicineP2CC (45)
Cea Car-T Cells
Pancreatic Neoplasm
Chongqing Precision Biotech Co., LtdP1/2CC (45)
Cea-Targeted Car-T
Pancreatic Neoplasm
Weijia Fang, MDP1/2CC (45)
Certepetide
Pancreatic Neoplasm
Qilu Pharmaceutical Co., Ltd.P1/2CC (45)
ct041 autologous car t-cell
Pancreatic Neoplasm
CARsgen Therapeutics Co., Ltd.P1/2CC (45)
Gamma1 Heavy Chain Humanized (1-450) [Vh (Homo Sapiens Ighv4-31*01 (89.9%) -(Ighd) -Ighj4*01 (92.9%), Cdr-Imgt [9.7.13] (26-34.52-58.97-109)) (1-120) -Homo Sapiens Ighg1*01 (100%), G1M17,1 Ch1 K120, D12, L14 (Ch1 K120 (217) (121-218), Hinge 1-15 (219-233), Ch2 (234-343), Ch3 D12 (359), L14 (361) (344-448), Chs (449-450)) (121-450)], (223-214')-Disulfide With Kappa Light Chain Humanized (1'-214') [V-Kappa (Homo Sapiens Igkv1-12*01 (85.3%)-Igkj2*01 (100%), Cdr-Imgt [6.3.9] (27-32.50-52.89-97)) (1'-107') -Homo Sapiens Igkc*01 (100%), Km3 A45.1 (153), V101 (191) (108'-214')]; Dimer (229-229'':232-232'')-Bisdisulfide, Produced In Chinese Hamster Ovary (Cho) Cells, Derived From The Cell Line Cho-K1,Glycoform Alfa
Pancreatic Neoplasm
Hummingbird BioscienceP1/2CC (45)
htl0039732 capsules
Pancreatic Neoplasm
Cancer Research UKP1/2CC (45)
Nogapendekin Alfa Inbakicept
Pancreatic Neoplasm
ImmunityBio, Inc.P2CC (45)
Olomorasib
Pancreatic Neoplasm
Eli Lilly and CompanyP1/2CC (45)
Petiveria Alliacea Preparation
Pancreatic Neoplasm
Hospital Universitario San IgnacioP1/2CC (45)
ucb4594
Pancreatic Neoplasm
Cancer Research UKP1/2CC (45)
Elraglusib
Pancreatic Neoplasm
Actuate Therapeutics Inc.P2CC (44)
Futibatinib
Pancreatic Neoplasm
Taiho Oncology, Inc.P2CC (44)
NC 410
Pancreatic Neoplasm
Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsP2CC (44)
Avelumab
Pancreatic Neoplasm
Fate TherapeuticsP1/2CC (43)
Rintatolimod
Pancreatic Neoplasm
AIM ImmunoTech Inc.P2CC (43)
Urelumab
Pancreatic Neoplasm
Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsP2CC (43)
e-602
Pancreatic Neoplasm
Palleon Pharmaceuticals, Inc.P1/2CC (42)
H-Gamma1 Heavy Chain Homo Sapiens (1-447) [Vh (Homo Sapiens Ighv4-59*01 (99.0%) -(Ighd) -Ighj3*02 (93.3%) T125>I (114), Cdr-Imgt [8.7.11] (26-33.51-57.96-106)) (1-117) -Homo Sapiens Ighg1*01, G1M17,1 Ch1 K120, Ch3 D12, L14, 9-G1V21 Ch2 Y15.1, T16, E18 (Ch1 K120 (214) (118-215), Hinge 1-15 (216-230), Ch2 M15.1>Y (252), S16>T (254), T18>E (256) (231-340), Ch3 D12 (356), L14 (358) (341-445), Chs (446-447)) (118-447)], (220-214')-Disulfide With L-Kappa Light Chain Homo Sapiens (1'-214') [V-Kappa (Homo Sapiens Igkv3-11*01 (96.8%) -Igkj4*01 (100%), Cdr-Imgt [6.3.9] (27'-32'.50'-52'.89'-97')) (1'-107') -Homo Sapiens Igkc*01 (100%) Km3 A45.1, V101 (Ckappa A45.1 (153'), V101 (191')) (108'-214')]; Dimer (226-226'':229-229'')-Bisdisulfide, Produced In A Cell Line Derived From Chinese Hamster Ovary (Cho) Cells, Glycoform Alfa
Pancreatic Neoplasm
Kineta Inc.P1/2CC (42)
Fapi-46
Pancreatic Neoplasm
Karolinska University HospitalP1CC (41)
Fluorthanatrace F-18
Pancreatic Neoplasm
Abramson Cancer Center at Penn MedicineP1CC (41)
Itraconazole
Pancreatic Neoplasm
Eli Lilly and CompanyP1CC (41)
kd-496
Pancreatic Neoplasm
Peking UniversityP1CC (41)
ly4170156
Pancreatic Neoplasm
Eli Lilly and CompanyP1CC (41)
Oxodotreotide
Pancreatic Neoplasm
National Cancer Institute (NCI)P1CC (41)
pf-08046049
Pancreatic Neoplasm
Seagen, a wholly owned subsidiary of PfizerP1CC (41)
Tcr-T Cells
Pancreatic Neoplasm
Beijing DCTY Biotech Co.,Ltd.P1CC (41)
Tnhyp217 Car T Cells
Pancreatic Neoplasm
National Cancer Institute (NCI)P1CC (41)
[111In]In-DOTA-ANTI-CEA antibody
Pancreatic Neoplasm
Radboud University Medical CenterP1/2CC (40)
64cu-lnth-1363s
Pancreatic Neoplasm
Lantheus Medical ImagingP1/2CC (40)
a2b530
Pancreatic Neoplasm
A2 Biotherapeutics Inc.P1/2CC (40)
Agen2373
Pancreatic Neoplasm
Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsP1/2CC (40)
Amxi-5001
Pancreatic Neoplasm
AtlasMedx, IncorporatedP1/2CC (40)
Anti-Hcd70 Car Transduced Pbl
Pancreatic Neoplasm
National Cancer Institute (NCI)P1/2CC (40)
Anti-Kras G12V Mtcr Pbl
Pancreatic Neoplasm
National Cancer Institute (NCI)P1/2CC (40)
Ast-001
Pancreatic Neoplasm
Ascentawits Pharmaceuticals, LtdP1/2CC (40)
Benzoic Acid, 4-((4-Amino-3-(4-Cyclohexyl-1-Piperazinyl)-9,10-Dihydro-9,10-Dioxo-1-Anthracenyl)Amino)-
Pancreatic Neoplasm
VM Oncology, LLCP1/2CC (40)
bhb810
Pancreatic Neoplasm
BigHat Biosciences, Inc.P1/2CC (40)
bnt141
Pancreatic Neoplasm
BioNTech SEP1/2CC (40)
BNT321
Pancreatic Neoplasm
BioNTech SEP1/2CC (40)
Bold-100
Pancreatic Neoplasm
Bold Therapeutics, Inc.P1/2CC (40)
Camizestrant
Pancreatic Neoplasm
AstraZenecaP1/2CC (40)
Claudin18.2 Car-T Cells
Pancreatic Neoplasm
Essen BiotechP1/2CC (40)
cts2190 capsules
Pancreatic Neoplasm
CytosinLab Therapeutics Co., Ltd.P1/2CC (40)
Cypate-Cyclo(Cys-Gly-Arg-Asp-Ser-Pro-Cys)-Lys-Oh (Ls301)
Pancreatic Neoplasm
Washington University School of MedicineP1/2CC (40)
Datopotamab Deruxtecan
Pancreatic Neoplasm
AstraZenecaP1/2CC (40)
Domvanalimab
Pancreatic Neoplasm
James Cleary, MD, PhDP1/2CC (40)
Egfr Fpbmc
Pancreatic Neoplasm
University of VirginiaP1/2CC (40)
Showing 151 to 200 of 377 assets
PreviousPage 4 of 8Next